Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays

Vaccine

Volumn 28, Issue 17, 2010, Pages 3014-3024

  Molina, Douglas M ^a   Pal, Sukumar ^b   Kayala, Mathew A ^c   Teng, Andy ^a   Kim, Paul J ^a   Baldi, Pierre ^c   Felgner, Philip L ^b   Liang, Xiaowu ^a   de la Maza, Luis M ^b  

^a ImmPORT Therapeutics Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Irvine   (United States)

Author keywords

Animal models; Antigens; Chlamydia trachomatis; Microarrays; Proteomics; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHLAMYDIA TRACHOMATIS ANTIGEN; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0052; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0189; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0582; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0660; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0726; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0816; CHLAMYDIA TRACHOMATIS ANTIGEN TC 0828; FREUND ADJUVANT; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; PROTEOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENOME; BACTERIAL IMMUNITY; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNIZATION; MALE; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; MOUSE STRAIN C3H HEN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TH1 CELL; TH2 CELL; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHLAMYDIA TRACHOMATIS; FEMALE; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PROTEIN ARRAY ANALYSIS; TH1 CELLS; TH2 CELLS;

EID: 77949872926     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.020     Document Type: Article

References (60)

1. Miller W.C., Ford C.A., Morris M., Handcock M.S., Schmitz J.L., Hubbs M.M., et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291 (2004) 2229-2236
2. Schachter J., and Dawson C. Human chlamydial infections (1978), PSG Publishing Co, Littleton
3. Grayston J.T., and Wang S. New knowledge of Chlamydiae and the diseases they cause. J Infect Dis 132 (1975) 87-105
4. Westrom L., Joesoef R., Reynolds G., Hagdu A., and Thompson S.E. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19 (1992) 185-192
5. Trends in reportable sexually transmitted diseases in the United States, 2007. National surveillance data for chlamydia, gonorrhea, and syphilis (2007), Centers for Disease Control and Prevention, United States p. 1-7
6. Grayston J.T., and Wang S.P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 5 (1978) 73-77
7. Taylor-Robinson D., and Thomas B.J. The role of Chlamydia trachomatis in genital-tract and associated diseases. J Clin Pathol 33 (1980) 205-233
8. Brunham R.C., and Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5 (2005) 149-161
9. Morrison R.P., and Caldwell H.D. Immunity to murine chlamydial genital infection. Infect Immun 70 (2002) 2741-2751
10. de la Maza M.A., and de la Maza L.M. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13 (1995) 119-127
11. Swenson C., Donegan E., and Schachter J. Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis 148 (1983) 1101-1107
12. Tuffrey M., and Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 12 (1981) 111-115
13. Pal S., Peterson E.M., and de la Maza L.M. New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun 72 (2004) 4210-4216
14. Pal S., Fielder T.J., Peterson E.M., and de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 62 (1994) 3354-3362
15. Pal S., Peterson E.M., and de la Maza L.M. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice. Immunology 110 (2003) 368-375
16. Pal S., Peterson E.M., and de la Maza L.M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 73 (2005) 8153-8160
17. Stephens R.S., Sanchez-Pescador R., Wagar E.A., Inouye C., and Urdea M.S. Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol 169 (1987) 3879-3885
18. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282 (1998) 754-759
19. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Ac Sci USA 102 (2005) 547-552
20. Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 95 (1942) 49-50
21. Caldwell H.D., Kromhout J., and Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31 (1981) 1161-1176
22. Pal S., Rangel J., Peterson E.M., and de la Maza L.M. Immunogenic and protective ability of the two developmental forms of Chlamydiae in a mouse model of infertility. Vaccine 18 (2000) 752-761
23. Fielder T.J., Pal S., Peterson E.M., and de la Maza L.M. Sequence of the gene encoding the major outer membrane protein of the mouse pneumonitis biovar of Chlamydia trachomatis. Gene 106 (1991) 137-138
24. de la Maza L.M., Pal S., Khamesipour A., and Peterson E.M. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 62 (1994) 2094-2097
25. Sundaresh S., Randal A., Unal B., Petersen J.M., Belisle J.T., Hartley M.G., et al. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 23 (2007) 508-513
26. Huber W., von Heydebreck A., Sultmann H., Poustka A., and Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (2002) S96-S104
27. Baldi P., and Long A.D. A Bavesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17 (2001) 509-519
28. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25 (1988) 1032-1037
29. Ionescu-Matiu I., Kennedy R.C., Sparrow J.T., Culwell A.R., Sanchez Y., Melnick J.L., et al. Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol 130 (1983) 1947-1952
30. Szmuness W., Stevens C.E., and Hatley E.J. Hepatitis vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303 (1980) 833-841
31. Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92 (1995) 11553-11557
32. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions'. N Engl J Med 356 (2007) 1915-1927
33. Sharma J., Zhong Y., Dong F., Piper J.M., Wang G., and Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infections using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 74 (2006) 1490-1499
34. Li D., Borovkov A., Vaglenov A., Wang C., Kim T., Gao D., et al. Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates. Vaccine 24 (2006) 2917-2927
35. Caldwell H.D., and Schachter J. Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun 36 (1982) 1024-1031
36. Lundemose A.G., Birkelund S., Fey S.J., Larsen P.M., and Christiansen G. Chlamydia trachomatis contains a protein similar to the Legionella pneumophila mip gene product. Mol Microbiol 5 (1991) 109-115
37. Bas S., Muzzin P., Ninet B., Bornand J.E., Scieux C., and Vischer T.L. Chlamydial serology: comparative diagnostic value of immunoblot, microimmunofluorescence test, and immunoassay using different recombinant proteins as antigens. J Clin Microbiol 39 (2001) 1368-1377
38. Raulston J.E., Miller J.D., Davis C.H., Schell M., Baldwin A., Ferguson K., et al. Identification of an iron-responsive protein that is antigenic in patients with Chlamydia trachomatis genital infections. FEMS Immunol Med Microbiol 51 (2007) 569-576
39. Newhall W.J. Biosynthesis and disulfide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis. Infect Immun 55 (1988) 162-168
40. Clarke I.N., Card M.E., and Lambden P.R. Molecular cloning and sequence analysis of a developmentally regulated cysteine-rich outer membrane protein from Chlamydia trachomatis. Gene 71 (1991) 307-314
41. de la Maza L.M., Fielder T.J., Carlson E.J., Markoff B.A., and Peterson E.M. Sequence diversity of the 60-kilodalton protein and of a putative 15-kilodalton protein between the trachoma and lymphogranuloma venereum biovars of Chlamydia trachomatis. Infect Immun 59 (1991) 1196-1201
42. Allen J.E., Cerrone M.C., Beatty P.R., and Stephens R.S. Cysteine-rich outer membrane proteins of Chlamydia tachomatis display compensatory changes between biovariants. Mol Microbiol 4 (1990) 1443-1450
43. Kimmel B., Bosserhoff A., Frank R., Gross R., Goebel W., and Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 68 (2000) 915-920
44. DelVecchio V.G., Connolly J.P., Alefantis T.G., Walz A., Quan M.A., Patra G., et al. Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringensis. Appl Environ Microbiol 72 (2006) 6355-6363
45. Fling S.P., Sutherland R.A., Steele L.N., Hess B., D'Orazio S.E., Maisonneuve J., et al. CD8+ T cells recognize an inclusion membrane-associated protein from vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci USA 98 (2001) 1160-1165
46. b allotype. J Immunol Methods 125 (1989) 207-213
47. Mosmann T.R., and Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7 (1989) 145-173
48. Wilson-Wleder J.H., Torres M.P., Kipper M.I., Mallapragada S.K., Wannemuehler M.J., and Nasasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 98 (2009) 1278-1316
49. Harandi A.M., Davies G., and Olesen O.F. Vaccine adjuvants: scientific challenges and strategic initiatives. Expert Rev Vaccines 8 (2009) 293-298
50. Erdile L.F., and Guy B. OspA lipoprotein of Borrelia burdorgferi is a mucosal immunogen and adjuvant. Vaccine 15 (1997) 988-995
51. Takahashi I., Marinaqro M., Kiyono H., Jackson R.J., Nakagawa I., Fujihashi K., et al. Mechanisms of mucosal immunogenicity and adjuvancy in Escherichia coli labile enterotoxins. J Infect Dis 173 (1996) 627-635
52. Darville T., Andrews C.W., Sikes J.D., Fraley P.L., Braswell L., and Rank R.G. Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun 69 (2001) 7419-7424
53. Eyles J.E., Unal B., Hartley M.G., Newstead S.S., Flick-Smith H., Prior J.L., et al. Immunodominant Francisella tularensis antigens identified using proteome microarray. Crown Copyright. Dsttl Proteomics 7 (2007) 2172-2183
54. Spandorfger S.D., Neuer A., LaVerda D., Byrne G.H.-C., Liu H.-C., Rosenwaks Z., et al. Previously undetected Chlamydia trachomatis infection, immunity to heat shock proteins and tubal oclusion in women undergoing in vitro fertilization. Hum Reprod 14 (1999) 60-64
55. Davies D.H.D., Molina D.M., Wrammert J., Miller J., Hirst S., Mu Y., et al. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7 (2007) 1678-1686
56. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez D., et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8 (2008) 4680-4694
57. Barbour A.G., Jasinskas A., Kayala M.A., Davies D.H., Steere A.C., Baldi P., et al. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdoferi. Infect Immun 76 (2008) 3374-3389
58. Sun G., Pal S., Sarcon A.K., Kim S., Sugawara T., Nikaido H., et al. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol 189 (2007) 6222-6235
59. Rodriguez-Marañon M.J., Bush R.M., Peterson E.M., Schirmer T., and de la Maza L.M. Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia. Protein Sci 11 (2002) 1854-1861
60. Yen T.Y., Pal S., and de la Maza L.M. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Biochemistry 44 (2005) 6250-6256